Trends in the utilization of medicines sold in the private sector post- registration in South Africa and the implications for similar countries.

Regulatory measures should be implemented to ensure increased medicine access post-registration for new originators, especially for priority disease areas that benefit patients. Mental health diseases and improved access to oncology medicines require special attention and further investigation in South Africa.